195 related articles for article (PubMed ID: 12132663)
1. Studies on intestinal absorption of sulpiride (1): carrier-mediated uptake of sulpiride in the human intestinal cell line Caco-2.
Watanabe K; Sawano T; Terada K; Endo T; Sakata M; Sato J
Biol Pharm Bull; 2002 Jul; 25(7):885-90. PubMed ID: 12132663
[TBL] [Abstract][Full Text] [Related]
2. Studies on intestinal absorption of sulpiride (3): intestinal absorption of sulpiride in rats.
Watanabe K; Sawano T; Jinriki T; Sato J
Biol Pharm Bull; 2004 Jan; 27(1):77-81. PubMed ID: 14709903
[TBL] [Abstract][Full Text] [Related]
3. Studies on intestinal absorption of sulpiride (2): transepithelial transport of sulpiride across the human intestinal cell line Caco-2.
Watanabe K; Sawano T; Endo T; Sakata M; Sato J
Biol Pharm Bull; 2002 Oct; 25(10):1345-50. PubMed ID: 12392092
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers.
Liang E; Proudfoot J; Yazdanian M
Pharm Res; 2000 Oct; 17(10):1168-74. PubMed ID: 11145220
[TBL] [Abstract][Full Text] [Related]
5. Multiple drug transporters mediate the placental transport of sulpiride.
Bai M; Ma Z; Sun D; Zheng C; Weng Y; Yang X; Jiang T; Jiang H
Arch Toxicol; 2017 Dec; 91(12):3873-3884. PubMed ID: 28597291
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter.
Wu X; Whitfield LR; Stewart BH
Pharm Res; 2000 Feb; 17(2):209-15. PubMed ID: 10751037
[TBL] [Abstract][Full Text] [Related]
7. Multiple organic cation transporters contribute to the renal transport of sulpiride.
Li L; Weng Y; Wang W; Bai M; Lei H; Zhou H; Jiang H
Biopharm Drug Dispos; 2017 Dec; 38(9):526-534. PubMed ID: 28926871
[TBL] [Abstract][Full Text] [Related]
8. Intestinal absorption mechanism of mirabegron, a potent and selective β₃-adrenoceptor agonist: involvement of human efflux and/or influx transport systems.
Takusagawa S; Ushigome F; Nemoto H; Takahashi Y; Li Q; Kerbusch V; Miyashita A; Iwatsubo T; Usui T
Mol Pharm; 2013 May; 10(5):1783-94. PubMed ID: 23560393
[TBL] [Abstract][Full Text] [Related]
9. Saturable absorptive transport of the hydrophilic organic cation ranitidine in Caco-2 cells: role of pH-dependent organic cation uptake system and P-glycoprotein.
Bourdet DL; Thakker DR
Pharm Res; 2006 Jun; 23(6):1165-77. PubMed ID: 16741655
[TBL] [Abstract][Full Text] [Related]
10. Do cell culture conditions influence the carrier-mediated transport of peptides in Caco-2 cell monolayers?
Behrens I; Kissel T
Eur J Pharm Sci; 2003 Aug; 19(5):433-42. PubMed ID: 12907294
[TBL] [Abstract][Full Text] [Related]
11. Transport of L-carnitine in human corneal and conjunctival epithelial cells.
Xu S; Flanagan JL; Simmons PA; Vehige J; Willcox MD; Garrett Q
Mol Vis; 2010 Sep; 16():1823-31. PubMed ID: 21045919
[TBL] [Abstract][Full Text] [Related]
12. New and better protocols for a short-term Caco-2 cell culture system.
Yamashita S; Konishi K; Yamazaki Y; Taki Y; Sakane T; Sezaki H; Furuyama Y
J Pharm Sci; 2002 Mar; 91(3):669-79. PubMed ID: 11920752
[TBL] [Abstract][Full Text] [Related]
13. Transport characteristics of differently charged cephalosporin antibiotics in oocytes expressing the cloned intestinal peptide transporter PepT1 and in human intestinal Caco-2 cells.
Wenzel U; Gebert I; Weintraut H; Weber WM; Clauss W; Daniel H
J Pharmacol Exp Ther; 1996 May; 277(2):831-9. PubMed ID: 8627565
[TBL] [Abstract][Full Text] [Related]
14. Functional characteristics of basolateral peptide transporter in the human intestinal cell line Caco-2.
Terada T; Sawada K; Saito H; Hashimoto Y; Inui K
Am J Physiol; 1999 Jun; 276(6):G1435-41. PubMed ID: 10362647
[TBL] [Abstract][Full Text] [Related]
15. Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells.
Englund G; Rorsman F; Rönnblom A; Karlbom U; Lazorova L; Gråsjö J; Kindmark A; Artursson P
Eur J Pharm Sci; 2006 Nov; 29(3-4):269-77. PubMed ID: 16822659
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of intestinal dipeptide transport by the neuropeptide VIP is an anti-absorptive effect via the VPAC1 receptor in a human enterocyte-like cell line (Caco-2).
Anderson CM; Mendoza ME; Kennedy DJ; Raldua D; Thwaites DT
Br J Pharmacol; 2003 Feb; 138(4):564-73. PubMed ID: 12598410
[TBL] [Abstract][Full Text] [Related]
17. Intestinal transport of irinotecan in Caco-2 cells and MDCK II cells overexpressing efflux transporters Pgp, cMOAT, and MRP1.
Luo FR; Paranjpe PV; Guo A; Rubin E; Sinko P
Drug Metab Dispos; 2002 Jul; 30(7):763-70. PubMed ID: 12065434
[TBL] [Abstract][Full Text] [Related]
18. Bacampicillin uptake is shared with thiamine in Caco-2 cells.
Oda M; Fujimoto K; Kobayashi M; Saitoh H
Biol Pharm Bull; 2007 Jul; 30(7):1344-9. PubMed ID: 17603179
[TBL] [Abstract][Full Text] [Related]
19. Functional domains in the carnitine transporter OCTN2, defective in primary carnitine deficiency.
Amat di San Filippo C; Wang Y; Longo N
J Biol Chem; 2003 Nov; 278(48):47776-84. PubMed ID: 14506273
[TBL] [Abstract][Full Text] [Related]
20. Peptide transporter substrate identification during permeability screening in drug discovery: comparison of transfected MDCK-hPepT1 cells to Caco-2 cells.
Balimane PV; Chong S; Patel K; Quan Y; Timoszyk J; Han YH; Wang B; Vig B; Faria TN
Arch Pharm Res; 2007 Apr; 30(4):507-18. PubMed ID: 17489369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
